DE69637948D1 - Substituierte imidazole mit krebsremmender und cytokininhibierender wirkung - Google Patents
Substituierte imidazole mit krebsremmender und cytokininhibierender wirkungInfo
- Publication number
- DE69637948D1 DE69637948D1 DE69637948T DE69637948T DE69637948D1 DE 69637948 D1 DE69637948 D1 DE 69637948D1 DE 69637948 T DE69637948 T DE 69637948T DE 69637948 T DE69637948 T DE 69637948T DE 69637948 D1 DE69637948 D1 DE 69637948D1
- Authority
- DE
- Germany
- Prior art keywords
- cancer
- cytokininhibieren
- breathers
- effect
- substituted imidazole
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US506395P | 1995-10-06 | 1995-10-06 | |
US505995P | 1995-10-06 | 1995-10-06 | |
GBGB9602907.9A GB9602907D0 (en) | 1996-02-13 | 1996-02-13 | Substituted imidazoles having anti-cancer and cytokine inhibitory activity |
GBGB9602975.6A GB9602975D0 (en) | 1996-02-13 | 1996-02-13 | Acyl heterocylcic substituted imidazoles having anti-cancer and cytokine inhibitory activity |
PCT/US1996/015880 WO1997012876A1 (en) | 1995-10-06 | 1996-10-02 | Substituted imidazoles having anti-cancer and cytokine inhibitory activity |
Publications (1)
Publication Number | Publication Date |
---|---|
DE69637948D1 true DE69637948D1 (de) | 2009-07-23 |
Family
ID=27451400
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69637948T Expired - Fee Related DE69637948D1 (de) | 1995-10-06 | 1996-10-02 | Substituierte imidazole mit krebsremmender und cytokininhibierender wirkung |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0854870B1 (de) |
JP (1) | JP3382951B2 (de) |
KR (1) | KR19990064117A (de) |
CN (1) | CN1117082C (de) |
AT (1) | ATE433446T1 (de) |
AU (1) | AU702146B2 (de) |
CA (1) | CA2234066C (de) |
CZ (1) | CZ292707B6 (de) |
DE (1) | DE69637948D1 (de) |
EA (1) | EA001203B1 (de) |
EE (1) | EE03681B1 (de) |
IL (1) | IL123950A (de) |
NO (1) | NO981528L (de) |
NZ (1) | NZ321738A (de) |
PL (1) | PL184819B1 (de) |
SK (1) | SK282496B6 (de) |
WO (1) | WO1997012876A1 (de) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5916891A (en) | 1992-01-13 | 1999-06-29 | Smithkline Beecham Corporation | Pyrimidinyl imidazoles |
US6046208A (en) * | 1996-01-11 | 2000-04-04 | Smithkline Beecham Corporation | Substituted imidazole compounds |
JP2000504023A (ja) * | 1996-04-03 | 2000-04-04 | メルク エンド カンパニー インコーポレーテッド | 癌治療方法 |
WO1998024782A2 (en) * | 1996-12-05 | 1998-06-11 | Amgen Inc. | Substituted pyrimidine compounds and their use |
EP1314731A3 (de) * | 1996-12-05 | 2004-01-02 | Amgen Inc. | Substituierte Pyrimidinverbindungen und ihre Verwendung |
US6410729B1 (en) | 1996-12-05 | 2002-06-25 | Amgen Inc. | Substituted pyrimidine compounds and methods of use |
US6096753A (en) | 1996-12-05 | 2000-08-01 | Amgen Inc. | Substituted pyrimidinone and pyridone compounds and methods of use |
WO1998024780A2 (en) * | 1996-12-05 | 1998-06-11 | Amgen Inc. | Substituted pyrimidinone and pyridinone compounds and their use |
US6608060B1 (en) | 1996-12-18 | 2003-08-19 | Vertex Pharmaceuticals Incorporated | Inhibitors of p38 |
US6147080A (en) * | 1996-12-18 | 2000-11-14 | Vertex Pharmaceuticals Incorporated | Inhibitors of p38 |
US5945418A (en) * | 1996-12-18 | 1999-08-31 | Vertex Pharmaceuticals Incorporated | Inhibitors of p38 |
CA2293436C (en) | 1997-06-12 | 2010-10-26 | Rhone-Poulenc Rorer Limited | Imidazolyl-cyclic acetals as tnf inhibitors |
US20020156104A1 (en) | 1997-06-13 | 2002-10-24 | Jerry L. Adams | Novel pyrazole and pyrazoline substituted compounds |
US6610695B1 (en) | 1997-06-19 | 2003-08-26 | Smithkline Beecham Corporation | Aryloxy substituted pyrimidine imidazole compounds |
GB9713726D0 (en) * | 1997-06-30 | 1997-09-03 | Ciba Geigy Ag | Organic compounds |
AU8381098A (en) | 1997-07-02 | 1999-01-25 | Smithkline Beecham Corporation | Novel cycloalkyl substituted imidazoles |
US6562832B1 (en) | 1997-07-02 | 2003-05-13 | Smithkline Beecham Corporation | Substituted imidazole compounds |
US7301021B2 (en) | 1997-07-02 | 2007-11-27 | Smithkline Beecham Corporation | Substituted imidazole compounds |
JP2001518507A (ja) | 1997-10-08 | 2001-10-16 | スミスクライン・ビーチャム・コーポレイション | 新規シクロアルケニル置換化合物 |
WO1999032121A1 (en) | 1997-12-19 | 1999-07-01 | Smithkline Beecham Corporation | Compounds of heteroaryl substituted imidazole, their pharmaceutical compositions and uses |
EP1080087A4 (de) | 1998-05-22 | 2001-11-21 | Smithkline Beecham Corp | Neue 2-alkyl-substituierte imidazole |
US6858617B2 (en) | 1998-05-26 | 2005-02-22 | Smithkline Beecham Corporation | Substituted imidazole compounds |
WO2000019824A1 (en) | 1998-10-07 | 2000-04-13 | Smithkline Beecham Corporation | Novel treatment for stroke management |
JP2002528506A (ja) | 1998-11-04 | 2002-09-03 | スミスクライン・ビーチャム・コーポレイション | ピリジン−4−イルまたはピリミジン−4−イル置換ピラジン |
SI1180518T1 (sl) * | 1999-04-23 | 2007-06-30 | Takeda Pharmaceutical | 5-piridil-1,3-azolne spojine, postopek za njihovo pripravo in njihova uporaba |
US7122666B2 (en) | 1999-07-21 | 2006-10-17 | Sankyo Company, Limited | Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses |
CA2381215A1 (en) | 1999-08-06 | 2001-02-15 | Takeda Chemical Industries, Ltd. | P38map kinase inhibitors |
US6759410B1 (en) | 1999-11-23 | 2004-07-06 | Smithline Beecham Corporation | 3,4-dihydro-(1H)-quinazolin-2-ones and their use as CSBP/p38 kinase inhibitors |
ES2249309T3 (es) | 1999-11-23 | 2006-04-01 | Smithkline Beecham Corp | Compuestos de 3,4-dihidro-(1h)quinazolin-2-ona como inhibidores de csbp/p39 kinasa. |
ES2241675T3 (es) | 1999-11-23 | 2005-11-01 | Smithkline Beecham Corporation | Compuestos de 3,4-dihidro-(1h)quinazolin-2-ona como inhibidores de cspb/p38 quinasa. |
US7235551B2 (en) | 2000-03-02 | 2007-06-26 | Smithkline Beecham Corporation | 1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases |
GB0005357D0 (en) * | 2000-03-06 | 2000-04-26 | Smithkline Beecham Plc | Compounds |
AU2001235838A1 (en) | 2000-03-06 | 2001-09-17 | Smithkline Beecham Plc | Imidazol derivatives as raf kinase inhibitors |
WO2001074811A2 (en) | 2000-03-30 | 2001-10-11 | Takeda Chemical Industries, Ltd. | Substituted 1,3-thiazole compounds, their production and use |
WO2001098268A2 (en) | 2000-06-21 | 2001-12-27 | Bristol-Myers Squibb Pharma Company | Piperidine amides as modulators of chemokine receptor activity |
FR2818978B1 (fr) * | 2000-12-28 | 2003-02-28 | Sod Conseils Rech Applic | Modulateurs de canaux sodiques derives de 2-piperidylimidazoles |
GB0112348D0 (en) * | 2001-05-19 | 2001-07-11 | Smithkline Beecham Plc | Compounds |
DE60310730T2 (de) | 2002-07-09 | 2007-05-16 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmazeutische zusammensetzungen aus anticholinergica und p38 kinase hemmern zur behandlung von erkrankungen der atemwege |
WO2004078116A2 (en) | 2003-03-03 | 2004-09-16 | Array Biopharma, Inc. | P38 inhibitors and methods of use thereof |
US7135575B2 (en) | 2003-03-03 | 2006-11-14 | Array Biopharma, Inc. | P38 inhibitors and methods of use thereof |
US7250434B2 (en) | 2003-12-22 | 2007-07-31 | Janssen Pharmaceutica N.V. | CCK-1 receptor modulators |
US20060035893A1 (en) | 2004-08-07 | 2006-02-16 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders |
PE20060777A1 (es) | 2004-12-24 | 2006-10-06 | Boehringer Ingelheim Int | Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas |
DK1981851T3 (da) | 2006-01-31 | 2012-03-19 | Array Biopharma Inc | Kinaseinhibitorer og fremgangsmåder til anvendelse deraf |
EP1992344A1 (de) | 2007-05-18 | 2008-11-19 | Institut Curie | P38 Alpha als therapeutisches Target für Erkrankungen, die mit einer FGFR3- Mutation assoziiert sind |
BRPI0908906A2 (pt) * | 2008-03-21 | 2019-09-24 | Novartis Ag | compostos heterocíclicos e usos dos mesmos |
WO2022186512A1 (ko) * | 2021-03-04 | 2022-09-09 | 한양대학교 에리카산학협력단 | 피리디닐 피라졸 유도체 또는 이의 약학적으로 허용가능한 염 및 이의 용도 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL104369A0 (en) * | 1992-01-13 | 1993-05-13 | Smithkline Beecham Corp | Novel compounds and compositions |
ZA945363B (en) * | 1993-07-21 | 1995-03-14 | Smithkline Beecham Corp | Novel compounds |
-
1996
- 1996-10-02 EE EE9800083A patent/EE03681B1/xx not_active IP Right Cessation
- 1996-10-02 CN CN96198718A patent/CN1117082C/zh not_active Expired - Fee Related
- 1996-10-02 WO PCT/US1996/015880 patent/WO1997012876A1/en not_active Application Discontinuation
- 1996-10-02 CZ CZ19981043A patent/CZ292707B6/cs not_active IP Right Cessation
- 1996-10-02 DE DE69637948T patent/DE69637948D1/de not_active Expired - Fee Related
- 1996-10-02 PL PL96326025A patent/PL184819B1/pl unknown
- 1996-10-02 JP JP51442897A patent/JP3382951B2/ja not_active Expired - Fee Related
- 1996-10-02 EP EP96937654A patent/EP0854870B1/de not_active Expired - Lifetime
- 1996-10-02 SK SK435-98A patent/SK282496B6/sk unknown
- 1996-10-02 AT AT96937654T patent/ATE433446T1/de not_active IP Right Cessation
- 1996-10-02 AU AU75143/96A patent/AU702146B2/en not_active Ceased
- 1996-10-02 KR KR1019980702598A patent/KR19990064117A/ko not_active Application Discontinuation
- 1996-10-02 NZ NZ321738A patent/NZ321738A/xx unknown
- 1996-10-02 IL IL12395096A patent/IL123950A/en not_active IP Right Cessation
- 1996-10-02 EA EA199800268A patent/EA001203B1/ru not_active IP Right Cessation
- 1996-10-02 CA CA002234066A patent/CA2234066C/en not_active Expired - Fee Related
-
1998
- 1998-04-03 NO NO981528A patent/NO981528L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ATE433446T1 (de) | 2009-06-15 |
EA001203B1 (ru) | 2000-12-25 |
JPH11514353A (ja) | 1999-12-07 |
CN1203590A (zh) | 1998-12-30 |
EE03681B1 (et) | 2002-04-15 |
IL123950A (en) | 2001-04-30 |
NZ321738A (en) | 1999-11-29 |
CA2234066A1 (en) | 1997-04-10 |
NO981528D0 (no) | 1998-04-03 |
AU702146B2 (en) | 1999-02-11 |
EP0854870A1 (de) | 1998-07-29 |
CN1117082C (zh) | 2003-08-06 |
CA2234066C (en) | 2005-12-13 |
SK43598A3 (en) | 1998-11-04 |
AU7514396A (en) | 1997-04-28 |
CZ292707B6 (cs) | 2003-11-12 |
JP3382951B2 (ja) | 2003-03-04 |
CZ104398A3 (cs) | 1998-07-15 |
SK282496B6 (sk) | 2002-02-05 |
EP0854870A4 (de) | 1999-01-07 |
PL184819B1 (pl) | 2002-12-31 |
NO981528L (no) | 1998-06-05 |
WO1997012876A1 (en) | 1997-04-10 |
KR19990064117A (ko) | 1999-07-26 |
EE9800083A (et) | 1998-10-15 |
EA199800268A1 (ru) | 1998-12-24 |
EP0854870B1 (de) | 2009-06-10 |
PL326025A1 (en) | 1998-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69637948D1 (de) | Substituierte imidazole mit krebsremmender und cytokininhibierender wirkung | |
DE69733135D1 (de) | Substituierte imidazole mit cytokinin-inhibirender wirkung | |
NO985864L (no) | Nye anti-virale forbindelser | |
DE69523169T2 (de) | Verwendung von Mangiferin oder seinen Derivaten zur kosmetischen Anwendung | |
DK0664126T3 (da) | Hæmning af trombin | |
DE69412049D1 (de) | Hemmung von dysfunctionalen Uterusblutungen | |
DK0652002T3 (da) | Anvendelse af 2-phenyl-3-aroylebenzothiophener til fremstilling af et medikament til hæmning af brusknedbrydning | |
DK0659427T3 (da) | 2-Phenyl-3-azoylbenzothiophener til forøgelse af thrombomodulinekspression | |
DE69229738D1 (de) | Antiseborrhoische zusammensetzung | |
RU94045271A (ru) | Применение 2-фенил-3-ароилбензотиофенов для ингибирования синдрома тернера | |
BR9307331A (pt) | Compostos neuroprotetores 3,4-dihidro-2(1ho-quinolona | |
MX9802732A (es) | Imidazolas substituidas que tienen actividad anticancer e inhibidora de citocina. | |
FI20021652A (fi) | Tratsodonin alkyylijohdannaisten valmistuksessa käyttökelpoisia välituotteita | |
DE69307414T2 (de) | Dipeptidderivate und diese als aktive Bestandteile enthaltendes prophylaktisches oder therapeutisches Mittel gegen Knochenkrankheiten | |
CA2257200A1 (en) | Substituted imidazoles having cytokine inhibitory activity | |
KR950008514A (ko) | 과산화지질이 관여하는 질환의 치료제 또는 예방제 | |
ATE124398T1 (de) | 1,3,4-trisubstituierte piperidin-derivate, ihre herstellung und verwendung. | |
KR950005921A (ko) | 상처 치료를 촉진시키기 위한 조성물 | |
ECSP951499A (es) | Compuestos ariltios | |
ATE155479T1 (de) | Neue cytarabin-derivate, ihre herstellung und verwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |